Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study.

Fatemeh Ghafouri Reza Ahangari Cohan Hilda Samimi Ali Hosseini Rad S M Mahmood Naderi Farshid Noorbakhsh Vahid Haghpanah

Published in: JMIR bioinformatics and biotechnology (2022)

Based on the results of this study, the multiepitope vaccine designed against the S and E proteins of SARS-CoV-2 may be considered as a new, safe, and efficient approach to combatting the COVID-19 pandemic.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease